Shi Jinhui, Li Ruiyue, Yang Siyu, Phang Yeelin, Zheng Changwu, Zhang Hongmei
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Evid Based Complement Alternat Med. 2020 Oct 19;2020:8205983. doi: 10.1155/2020/8205983. eCollection 2020.
(LC) is a Chinese materia medica which is widely used in clinical settings to treat headaches, blood extravasation, and arthritis. Recent studies demonstrate that LC possesses versatile pharmacological functions, including antiatherosclerosis, antimigraine, antiaging, and anticancer properties. Moreover, LC also shows protective effects in the progression of different diseases that damage somatic cells. Oxidative stress and inflammation, which can induce somatic cell apoptosis, are the main factors associated with an abundance of diseases, whose progresses can be reversed by LC. In order to comprehensively review the molecular mechanisms associated with the protective effects of LC, we collected and integrated all its related studies on the anti-inflammatory, antioxidant, and antiapoptotic effects. The results show that LC could exhibit the mentioned biological activities by modulating several signaling pathways, specifically the NF-B, Nrf2, protein kinase, and caspase-3 pathways. In future investigations, the pharmacokinetic properties of bioactive compounds in LC and the signaling pathway modulation of LC could be focused.
LC是一种中药,在临床环境中广泛用于治疗头痛、出血和关节炎。最近的研究表明,LC具有多种药理功能,包括抗动脉粥样硬化、抗偏头痛、抗衰老和抗癌特性。此外,LC在损害体细胞的不同疾病进展中也显示出保护作用。氧化应激和炎症可诱导体细胞凋亡,是与多种疾病相关的主要因素,而LC可逆转这些疾病的进展。为了全面综述与LC保护作用相关的分子机制,我们收集并整合了所有关于其抗炎、抗氧化和抗凋亡作用的相关研究。结果表明,LC可通过调节多种信号通路,特别是NF-κB、Nrf2、蛋白激酶和caspase-3通路,表现出上述生物活性。在未来的研究中,可关注LC中生物活性化合物的药代动力学特性以及LC的信号通路调节。